Chemoresistance factors in non-small cell lung cancer
Lung cancer takes the leading position in cancer morbidity and mortality structure in the world and Ukraine. Advanced stages are diagnosed in more than 70% of lung cancer patients. Chemotherapy remains the main method of treatment for advanced lung cancer. Currently, the standard of chemotherapy in...
Saved in:
Main Authors: | А. I. Shevchenko (Author), А. P. Коlesnik (Author), А. V. Каdzhoian (Author), V. А. Кuzmenko (Author) |
---|---|
Format: | Book |
Published: |
Zaporozhye State Medical University,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PERSONALLY ORIENTED TRAINING - A NECESSARY CONDITION FOR THE HUMANIZATION OF SCHOOL LIFE
by: К.А. Baltremus
Published: (2002) -
The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer
by: Xiao-mian Lin, et al.
Published: (2019) -
TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53
by: Lv Y, et al.
Published: (2016) -
Modern management of leukemoid reactions
by: D.V. Dobrianskyi, et al.
Published: (2024) -
Prognostic role of epidermal growth factor receptors' expression in patients with i-ii stage of non-small cell lung cancer
by: A.P. Kolesnik, et al.
Published: (2013)